MedPath
HSA Approval

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

SIN15343P

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

October 13, 2017

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Licence HolderUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

N03AG01

valproic acid

Manufacturer Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

CP PHARMACEUTICALS LIMITED

Active Ingredients

Sodium valproate

100.0mg/ml

Valproic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml - HSA Approval | MedPath